OTC Markets EXMKT - Delayed Quote USD

Nemaura Medical Inc. (NMRD)

0.0001
0.0000
(0.00%)
As of May 14 at 4:00:00 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
0
77.0440
503.9060
0
Cost of Revenue
1,478.1090
1,553.4360
344.3000
0
Gross Profit
-1,478.1090
-1,476.3920
159.6060
0
Operating Expense
10,298.8680
7,138.8030
7,730.0370
4,586.7410
Operating Income
-11,776.9770
-8,615.1950
-7,570.4310
-4,586.7410
Net Non Operating Interest Income Expense
-5,667.5630
-6,412.5010
-6,666.6300
-2,007.6870
Other Income Expense
6,793.6070
883.9610
--
--
Pretax Income
-10,650.9330
-14,143.7350
-14,237.0610
-6,594.4280
Tax Provision
--
0
-350.2560
-335.8320
Net Income Common Stockholders
-10,650.9330
-14,143.7350
-13,886.8050
-6,258.5960
Diluted NI Available to Com Stockholders
-10,650.9330
-14,143.7350
-13,886.8050
-6,258.5960
Basic EPS
-0.39
-0.57
-0.59
-0.28
Diluted EPS
-0.39
-0.57
-0.59
-0.28
Basic Average Shares
28,475.3500
24,878.1960
23,383.7580
22,283.3770
Diluted Average Shares
28,475.3500
24,878.1960
23,383.7580
22,283.3770
Total Operating Income as Reported
-12,757.0160
-9,595.2340
-7,570.4310
-4,586.7410
Total Expenses
11,776.9770
8,692.2390
8,074.3370
4,586.7410
Net Income from Continuing & Discontinued Operation
-10,650.9330
-14,143.7350
-13,886.8050
-6,258.5960
Normalized Income
-17,444.5400
-15,027.6960
-13,886.8050
-6,258.5960
Interest Income
3.9260
--
--
--
Interest Expense
5,667.5630
6,412.5010
6,666.6300
2,007.6870
Net Interest Income
-5,667.5630
-6,412.5010
-6,666.6300
-2,007.6870
EBIT
-4,983.3700
-7,731.2340
-7,570.4310
-4,586.7410
EBITDA
-4,498.1040
-7,287.0570
-7,340.6210
-4,488.6660
Reconciled Cost of Revenue
1,478.1090
1,553.4360
344.3000
0
Reconciled Depreciation
485.2660
444.1770
229.8100
98.0750
Net Income from Continuing Operation Net Minority Interest
-10,650.9330
-14,143.7350
-13,886.8050
-6,258.5960
Total Unusual Items Excluding Goodwill
6,793.6070
883.9610
0
--
Total Unusual Items
6,793.6070
883.9610
0
--
Normalized EBITDA
-11,291.7110
-8,171.0180
-7,340.6210
-4,488.6660
Tax Rate for Calcs
0
0
0
0.0001
Tax Effect of Unusual Items
0
0
0
0
3/31/2021 - 12/18/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

A2P.F Synektik Spólka Akcyjna
53.95
-0.46%
 
FA0.F PExA AB (publ)
0.0135
0.00%
 
EPIS-B.ST Episurf Medical AB (publ)
0.1110
+1.09%
 
NEOLA.ST Neola Medical AB (publ)
2.4100
-0.82%
 
LT3.F Axogen, Inc.
10.30
+7.85%
 
PHIAa.XC
 
CGHC Capital Group Holdings, Inc.
0.0002
0.00%
 
SYK.BE Stryker Corp
343.60
-0.55%
 
SUN.L Surgical Innovations Group plc
0.6500
0.00%
 
SHL.DU Siemens Healthineers AG
48.18
+0.15%